Proposal (business)

LogicMark Shares Letter Reminding Shareholders to Vote “For” the August 25, 2022 Annual Meeting Proxy Proposals to Continue to Improve Operations, Manage Costs More Effectively and Reduce Potential Future Shareholder Dilution

Retrieved on: 
Monday, August 22, 2022
PERS, Technology, Safety, Proxy, New Board, Common stock, Maintenance, LGMK, U.S. Securities and Exchange Commission, GLOBE, Leadership, Company, Adoption, Board of directors, Telephone, Caregiver, Artificial intelligence, Board, Proposal, AND, SEC, Secretary of State of Nevada, Machine learning, LGBT healthcare in the United States Veterans Health Administration, Proxy statement, Intellectual property, BPM, Industry, Security (finance), Senior management, Solution, Proposal (business), Glass, Patent, Annual general meeting, NUALS Arts and Literary Annual Meet, Private Securities Litigation Reform Act, Growth, Health, Marketing, Letter, Consultant, ISS, Annual, Forward-looking statement, Management, Risk management, Director, Nasdaq

Shareholders as of the 2022 Annual Meeting record date, June 28, 2022, will be entitled to vote at the 2022 Annual Meeting.

Key Points: 
  • Shareholders as of the 2022 Annual Meeting record date, June 28, 2022, will be entitled to vote at the 2022 Annual Meeting.
  • LogicMark has taken considerable steps to improve its operations and strategic offerings, and the Company seeks to continue with this progress.
  • Vote For for Proposal No 3: To consider and vote on a proposal to adopt the Companys 2022 Stock Incentive Plan.
  • Forward-looking statements reflect managements current expectations, as of the date of this press release, and involve certain risks and uncertainties.

LogicMark, Inc. Issues Letter Urging Shareholders to Vote “For” All Annual Meeting Proxy Proposals to Strengthen the Company’s Ability to Create Lasting Shareholder Value

Retrieved on: 
Monday, August 8, 2022
NUALS Arts and Literary Annual Meet, Machine learning, U.S. Securities and Exchange Commission, Proxy, Proposal (business), Board of directors, Intelligence, Industry, Forward-looking statement, GLOBE, Technology, Annual general meeting, Private Securities Litigation Reform Act, SEC, Growth, Board, Director, Patent, Security (finance), Proxy statement, Annual, LGBT healthcare in the United States Veterans Health Administration, Marketing, Letter, Company, New Board, AND, Foundation, Proposal, LGMK, Maintenance, Solution, BPM, PERS, Consultant, Common stock, Adoption, Management, Risk management, Nasdaq

Our upcoming annual meeting and proxy proposals require your support as the means to further strengthen LogicMark and position the Company for lasting shareholder value creation.

Key Points: 
  • Our upcoming annual meeting and proxy proposals require your support as the means to further strengthen LogicMark and position the Company for lasting shareholder value creation.
  • Shareholders as of the annual meeting record date, June 28, 2022, will be entitled to vote at the annual meeting.
  • Forward-looking statements reflect managements current expectations, as of the date of this press release, and involve certain risks and uncertainties.
  • The Companys actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors.

LogicMark, Inc. Shares Why Upcoming Vote is Important to Help Continue Improving Operations, Effectively Manage Costs and Reduce Potential Future Dilution

Retrieved on: 
Monday, July 25, 2022
Nxt, LLP, New Board, Senior management, Board of directors, GLOBE, Consultant, Industry, U.S. Securities and Exchange Commission, BPM, Maintenance, Artificial intelligence, Forward-looking statement, SEC, Common stock, Intellectual property, Solution, Private Securities Litigation Reform Act, Health, Marketing, Patent, Board, Proposal, Safety, Machine learning, Annual, Adoption, Leadership, PERS, Technology, Proposal (business), Company, Security (finance), LGMK, Secretary of State of Nevada, Growth, LGBT healthcare in the United States Veterans Health Administration, Financial management, Management, Risk management, Director, Nasdaq

Shareholders as of the annual meeting record date, June 28, 2022, will be entitled to vote at the annual meeting.

Key Points: 
  • Shareholders as of the annual meeting record date, June 28, 2022, will be entitled to vote at the annual meeting.
  • A vote for each proposal will help enable LogicMark to, as applicable, continue to improve its operations, manage its costs more effectively and reduce potential future shareholder dilution.
  • LogicMark has taken considerable steps to improve its operations and strategic offerings, and the Company seeks to continue with this progress.
  • Vote For for Proposal No 3: To consider and vote on a proposal to adopt the Companys 2022 Stock Incentive Plan.

Effissimo Capital Management: Our Thinking as It Relates to Proposal No. 3 at Toshiba Corporation’s Extraordinary General Meeting of Shareholders

Retrieved on: 
Tuesday, March 22, 2022
Other Manufacturing, Finance, Hardware, Consumer Electronics, Professional Services, Technology, Semiconductor, Manufacturing, Board, Proposal (business), Toshiba, Director, Management

At the Extraordinary General Meeting of Shareholders for Toshiba Corporation (Toshiba), to be held on March 24, 2022, Proposal No.

Key Points: 
  • At the Extraordinary General Meeting of Shareholders for Toshiba Corporation (Toshiba), to be held on March 24, 2022, Proposal No.
  • The views of Effissimo Capital Management Pte Ltd (We, Our) on this proposal are explained below.
  • We announced in a March 10, 2022 press release that we cannot support Proposal No.
  • This is one of the credible options that would help Toshiba form a robust management structure trusted by shareholders and other stakeholders.

Procaps Group Announces Launch of Private Placement of U.S. $115 Million Senior Notes

Retrieved on: 
Thursday, September 9, 2021
Software, General Health, Professional Services, Pharmaceutical, Medical Devices, Technology, Hospitals, Biotechnology, Medical Supplies, Finance, Health, Diabetes, the Proposed Business Combination with Union Acquisition Corp. II, Procaps Group, Union Acquisition Corp. II, Prudential Private Capital, THE PROPOSED BUSINESS COMBINATION WITH UNION ACQUISITION CORP. II, PROCAPS GROUP, UNION ACQUISITION CORP. II, PRUDENTIAL PRIVATE CAPITAL

The private placement of the Senior Notes is expected to close on or about October 2021, subject to customary closing conditions.

Key Points: 
  • The private placement of the Senior Notes is expected to close on or about October 2021, subject to customary closing conditions.
  • The closing of the private placement of the Senior Notes is not conditioned upon the closing of the Business Combination.
  • The Senior Notes will be senior unsecured obligations of Procaps and unconditionally guaranteed by Procaps Group, Holdco (as defined below) and certain subsidiary guarantors.
  • This private placement of Senior Notes is expected to give Procaps Group additional financial flexibility to execute its growth strategy by refinancing current obligations at a lower interest and with an increased repayment duration, said Ruben Minski, Procaps Group Founder, Chairman and Chief Executive Officer.

Procaps Group Unveils New Videos Featuring Corporate Manufacturing and R&D Facilities in Latin America

Retrieved on: 
Monday, August 23, 2021
Hospitals, Pharmaceutical, Health, Medical Supplies, LLC, Brickell, Register, Growth, Group, Securities Act of 1933, Proxy, U.S. Securities and Exchange Commission, Form, Acquisition, SEC, Attention, Proposal (business), Nasdaq, Chief executive officer, Person, Research, Forward-looking statement, Multimedia, NASDAQ, Prospectus, PIPE, OTC, Failure, Registration statement, CEO, Form F-4, Sale, COVID-19, F-4, IFC, Plasma protein binding, Security (finance), Risk management, the Proposed Business Combination with Union Acquisition Corp. II, Procaps Group, Union Acquisition Corp. II., THE PROPOSED BUSINESS COMBINATION WITH UNION ACQUISITION CORP. II, PROCAPS GROUP, UNION ACQUISITION CORP. II.

Procaps Group, a leading integrated international healthcare and pharmaceutical company, announced that in conjunction with Procaps Groups recent virtual analyst day and second quarter 2021 earnings results, it has released two new videos showcasing its Manufacturing and Research & Development facilities across Latin America.

Key Points: 
  • Procaps Group, a leading integrated international healthcare and pharmaceutical company, announced that in conjunction with Procaps Groups recent virtual analyst day and second quarter 2021 earnings results, it has released two new videos showcasing its Manufacturing and Research & Development facilities across Latin America.
  • Links to the webcast of the presentation and its new corporate facility tour videos are available on the Procaps Group investor relations website here .
  • The combined company will be led by Ruben Minski, Procaps Group Founder, Chairman & CEO.
  • Procaps has a direct presence in 13 countries in Latin America and, as of December 31, 2020, had more than 4,700 collaborators working under a sustainable model.

Procaps Group Appoints Patricio Vargas as Global Chief Financial Officer to Support Global Expansion

Retrieved on: 
Tuesday, August 17, 2021
General Health, Hospitals, Health, Pharmaceutical, Medical Supplies, LLC, Brickell, Nasdaq, Register, Growth, Securities Act of 1933, Proxy, U.S. Securities and Exchange Commission, Form, Acquisition, SEC, Attention, Proposal (business), Chief executive officer, Person, Forward-looking statement, NASDAQ, Prospectus, PIPE, OTC, Failure, Registration statement, CEO, Sale, Completion, COVID-19, F-4, IFC, Plasma protein binding, Security (finance), Risk management, the Proposed Business Combination with Union Acquisition Corp. II, Procaps Group, Union Acquisition Corp. II., THE PROPOSED BUSINESS COMBINATION WITH UNION ACQUISITION CORP. II, PROCAPS GROUP, UNION ACQUISITION CORP. II.

If you have difficulty connecting with the conference call, please contact MZ Group at +1 (949) 491-8235.

Key Points: 
  • If you have difficulty connecting with the conference call, please contact MZ Group at +1 (949) 491-8235.
  • The combined company will be led by Ruben Minski, Procaps Group Founder, Chairman & CEO.
  • Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents.
  • The Registration Statement includes audited consolidated financial statements of Procaps Group as of and for the fiscal years ended December 31, 2020 and 2019.

Procaps Group Reports Record Second Quarter 2021 Financial Results

Retrieved on: 
Thursday, August 12, 2021
Software, General Health, Professional Services, Pharmaceutical, Medical Devices, Technology, Hospitals, Biotechnology, Medical Supplies, Finance, Health, Diabetes, Forward-looking statement, GlaxoSmithKline, Form, History, Prospectus, Ageing, B2C, ESG, Securities Act of 1933, Proposal (business), Growth, Sale, SPAC, Safety, Industry, IFC, Registration statement, EV, Company, Person, SEC, FDA, Register, Attention, Plasma protein binding, Abbott, Nasdaq, PPE, Population, HR, CEO, Pfizer, COVID-19, LLC, U.S. Securities and Exchange Commission, Failure, CDMO, Brickell, Chief executive officer, Absenteeism, Transport, NASDAQ, Proxy, PIPE, OTC, F-4, Acquisition, IFRS, Pharmaceutical industry, Cryptocurrency, Security (finance), Bank, Risk management, Fine chemical, Financial services, the Proposed Business Combination with Union Acquisition Corp. II, Procaps Group, Union Acquisition Corp. II., THE PROPOSED BUSINESS COMBINATION WITH UNION ACQUISITION CORP. II, PROCAPS GROUP, UNION ACQUISITION CORP. II.

Other finance costs adjustments represent non-operating expenses incurred by Procaps, primarily including additional interests incurred by Procaps due to the withholding tax obligations of certain financial institutions outside of Colombia.

Key Points: 
  • Other finance costs adjustments represent non-operating expenses incurred by Procaps, primarily including additional interests incurred by Procaps due to the withholding tax obligations of certain financial institutions outside of Colombia.
  • The combined company will be led by Ruben Minski, Procaps Group Founder, Chairman & CEO.
  • Procaps Group expects full-year Adjusted EBITDA margin expansion from 18% in 2019 to 26% in 2021 with strong positive free cash flow.
  • The Registration Statement includes audited consolidated financial statements of Procaps Group as of and for the fiscal years ended December 31, 2020 and 2019.